<DOC>
	<DOCNO>NCT01499498</DOCNO>
	<brief_summary>This healthy volunteer study look interaction two drug : boceprevir sildenafil . New drug develop treat people chronic viral infection hepatitis C. Very little know new treatment interact medication drug use treat erectile dysfunction . The purpose study look level new hepatitis C drug call boceprevir ( BOC ) exist erectile dysfunction drug call sildenafil see affect blood level give separately together .</brief_summary>
	<brief_title>The Boceprevir Sildenafil Pharmacokinetics Study</brief_title>
	<detailed_description>Total duration participant 40 day plus screen visit 1 - 3 week prior start study . They visit clinic 10 occasion : screen visit , baseline visit ( day 0 ) , day 1 , visit day 4 7 , day 10 , day 14 , day 15 , day 16 , day 17 follow visit day 26 40 . The total amount blood collect participant entire study great 350 ml total ( around 23 tablespoon ) . At screen visit clinical assessment perform . At baseline visit participant attend clinic fast required remain unit approximately 14 hour . On morning visit clinical assessment perform . Sildenafil 25mg ( 1 tablet ) administer standardised meal . Blood sample take follow time order measure level sildenafil blood : predose,0.5 , 1 , 2 , 3 , 4 , 6 , 8 , 10,12 24 hour post dose . On day Day 10 boceprevir initiate 800mg ( 4 capsule 3 time day ) next 4 day day 14 participant attend clinic witness dose boceprevir safety assessment . On day 15 participant attend 2nd long visit ( 10 hour ) administer boceprevir ( BOC ) 800mg ( 4 capsule ) standardise meal blood sample take follow time order measure level BOC blood : predose,0.5 , 1 , 2 , 3 , 4 , 6 8 hour post dose . After 8 hour blood collection participant administer boceprevir ( BOC ) 800mg ( 4 capsule ) food self administer BOC 800mg ( 4 capsule ) food home 8 hour later . On day 16 participant attend 3rd long visit ( 14 hour ) administer boceprevir ( BOC ) 800mg ( 4 capsule ) sildenafil 25mg standardised meal . Blood sample take follow time order measure level BOC sildenafil blood : predose,0.5 , 1 , 2 , 3 , 4 , 6 8 hour post dose . After 8 hour blood collection participant administer boceprevir ( BOC ) 800mg ( 4 capsule ) food self administer BOC 800mg ( 4 capsule ) food home 8 hour later . This last dose study medication . They return next day final blood test post 24 hour . A final visit day 26 40 perform include clinical assessment .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>The ability understand sign write informed consent form , prior participation screening procedure must willing comply study requirement . Subjects good health upon medical history , physical exam , laboratory test BMI &lt; 32 . Subjects heterosexually active must use two form barrier contraception ( e.g. , condom spermicide ) heterosexual intercourse , screen completion study include 10 day follow last dose study drug . Have serologic evidence HIV HCV infection antibody test screen . Have screen laboratory result ( haematology , chemistry ) fall within normal range central laboratory 's reference range unless result determine Investigator clinical relevance Any serious active medical psychiatric illness , opinion Investigator , would interfere subject treatment , assessment , compliance protocol . This would include active clinically significant renal , cardiac , hepatic , pulmonary , vascular , metabolic ( thyroid disorder , adrenal disease ) , immunodeficiency disorder , active infection , malignancy . Previous participation investigational trial involve administration investigational compound within 1 month prior study screen . Clinically relevant alcohol drug use ( positive drug screen ) history alcohol drug use consider Investigator sufficient hinder compliance treatment , followup procedure evaluation adverse event . Smoking permit , tobacco intake remain consistent throughout study . Any medication take list protocol include overthecounter medication herbal product within 21 day commence study drug dose exception vitamin and/or paracetamol . When concomitant medication necessary , review Investigator contraindicate , may continue dose frequency study period . History drug sensitivity drug allergy opinion investigator may put subject increase risk drug reaction study . Subjects female partner pregnant allow enter study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>